Ebiquity FY25 saw revenues down, profits squeezed and a £10m goodwill hit in North America, but cash flow improved and a strategic reshuffle is underway.
This article covers information on Ebiquity PLC.
LON:EBQEbiquity has posted FY25 results that land in line with January’s trading update. Revenue fell 4% to £73.4 million, adjusted operating profit dropped 42% to £4.6 million, and a £10.0 million non-cash impairment in North America dragged the Group to a statutory loss.
There is good news on cash and discipline. Free cash flow swung to a £3.1 million inflow, net debt reduced to £13.1 million, and management has tightened cost control, revamped leadership and pushed hard on proprietary tech and AI. The message is simple: 2025 was tough, the reset is done, and Ebiquity is aiming to return to growth.
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | £73.4m | £76.8m | -4% |
| Adjusted operating profit | £4.6m | £7.9m | -42% |
| Adjusted operating margin | 6.3% | 10.3% | -4.0pp |
| Adjusted profit before tax | £1.1m | £6.5m | -82% |
| Adjusted EPS | (1.39p) | 3.17p | – |
| Statutory loss before tax | £(12.1)m | £(2.3)m | – |
| Free cash flow | £3.1m | £(2.6)m | +£5.7m |
| Net debt (excl. restricted cash) | £13.1m | £15.6m | £2.5m better |
| Impairment charge (North America) | £10.0m | £- | Non-cash |
North America is the clear pain point: revenue down 22.8% and a £10.0 million impairment wiped out the region’s acquired goodwill. Management points to macro headwinds, elongated decision cycles and project deferrals. In response, Ebiquity appointed a new Managing Director for the Americas in June 2025, restructured the leadership team, broke down silos, and refocused on profitable client relationships.
The recovery narrative has early validation. Q1 2026 started “encouragingly” and the Group has secured marketing effectiveness engagements with an aggregate contract value of more than £10 million over three years. It is not a full turnaround yet, but commercial momentum matters after a bruising 2025.
Despite lower profits, cash performance improved notably. Adjusted cash from operations rose to £12.8 million, helped by a £4.7 million working capital inflow. Free cash flow swung to a £3.1 million inflow, and net debt fell to £13.1 million from £15.6 million.
Banking flexibility has been reinforced. In April 2026, Ebiquity amended and extended its revolving credit facility to £28 million, maturing in October 2027, with SONIA plus a 2.75% to 3.35% margin depending on leverage. Covenants look calibrated to current trading. For a business resetting its cost base and targeting growth, this runway is useful.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
40 viewsLikes
No ratings yet
Last updated:
Leadership has been overhauled: new CFO, COO, MDs for Australia and the Americas, and fresh roles in 2026 for a Managing Director of Marketing Transformation and a Head of Growth, Americas. A new Staff Cost to Profit Conversion KPI was embedded into FY26 budgets to hard-wire profitability into engagements.
On technology, Ebiquity deployed ERAbot, a proprietary agentic AI assistant, to over three quarters of staff by end FY25 and now over 90%. The aim is higher productivity plus richer insights from the Media Data Vault, with more client-facing AI features and Total TV expansion planned for 2026. It is a sensible route to scale expertise without bloating headcount.
The tone is cautiously upbeat. Management says decisive actions on leadership, operations and technology position the Group to return to growth. Q1 2026 trading was encouraging and the £10 million-plus of multi-year engagements provides some baseline activity. Equally, the ad market has been choppy, particularly in North America, and Ebiquity will need Q2 to firm up full-year visibility.
Positives: strong UK&I performance, Contract Compliance growth, improved cash generation, lower net debt, and a refocused North America with experienced leadership. Negatives: a sharp margin reset to 6.3%, statutory losses, and the credibility hit implied by a large impairment and halved share price in 2025. The job now is delivery.
Ebiquity’s FY25 shows a business that took its medicine. The impairment and profit squeeze lay bare a difficult year, especially in North America. But the balance sheet is steadier, the leadership bench is deeper, and operational discipline has sharpened. If the early 2026 momentum carries through and margins rebuild, this reset could mark the trough. The next checkpoint is Q2 trading colour and June’s capital markets day.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.